出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/06/09 16:38:48」(JST)
Clostridium | |
---|---|
SEM micrograph of Clostridium difficile colonies from a stool sample | |
Scientific classification | |
Domain: | Bacteria |
Phylum: | Firmicutes |
Class: | Clostridia |
Order: | Clostridiales |
Family: | Clostridiaceae |
Genus: | Clostridium Prazmowski 1880 |
Selected species | |
C. acetobutylicum |
Clostridium is a genus of Gram-positive bacteria, belonging to the Firmicutes. They are obligate anaerobes capable of producing endospores.[1][2] Individual cells are rod-shaped, which gives them their name, from the Greek kloster (κλωστήρ) or spindle. These characteristics traditionally defined the genus; however many species originally classified as Clostridium have been reclassified in other genera.
Clostridium consists of around 100 species[3] that include common free-living bacteria as well as important pathogens.[4] There are five main species responsible for disease in humans.
Clostridium is sometimes found in raw swiftlet nests, a Chinese delicacy. Nests are washed in a sulfite solution to kill the bacteria before being exported to the U.S.[12]
Neurotoxin production is the unifying feature of the species C. botulinum. Eight types of toxins have been identified and allocated a letter (A-H).[13] Most strains produce one type of neurotoxin but strains producing multiple toxins have been described. C. botulinum producing B and F toxin types have been isolated from human botulism cases in New Mexico and California. The toxin type has been designated Bf as the type B toxin was found in excess of the type F. Similarly, strains producing Ab and Af toxins have been reported. Organisms genetically identified as other Clostridium species have caused human botulism; Clostridium butyricum producing type E toxin and Clostridium baratii producing type F toxin. The ability of C. botulinum to naturally transfer neurotoxin genes to other Clostridium species is concerning, especially in the food industry where preservation systems are designed to destroy or inhibit only C. botulinum but not other Clostridium species.
C. thermocellum can utilize lignocellulosic waste and generate ethanol, thus making it a possible candidate for use in production of ethanol fuel. It also has no oxygen requirement and is thermophilic, which reduces cooling cost.
C. acetobutylicum, also known as the Weizmann organism, was first used by Chaim Weizmann to produce acetone and biobutanol from starch in 1916 for the production of gunpowder and TNT.
C. botulinum produces a potentially lethal neurotoxin that is used in a diluted form in the drug Botox, which is carefully injected to nerves in the face, which prevents the movement of the expressive muscles of the forehead, to delay the wrinkling effect of aging. It is also used to treat spasmodic torticollis and provides relief for approximately 12 to 16 weeks.[14]
C. butyricum MIYAIRI 588 strain is marketed in Japan, Korea and China for C. difficile prophylaxis due to its reported ability to interfere with the growth of that highly pathogenic organism.
The anaerobic bacterium C. ljungdahlii, recently discovered in commercial chicken wastes, can produce ethanol from single-carbon sources including synthesis gas, a mixture of carbon monoxide and hydrogen that can be generated from the partial combustion of either fossil fuels or biomass. Use of these bacteria to produce ethanol from synthesis gas has progressed to the pilot plant stage at the BRI Energy facility in Fayetteville, Arkansas.[15]
Fatty acids are converted by yeasts to long-chain dicarboxylic acids and then to 1,3-propanediol using Clostridium diolis.[citation needed]
Genes from C. thermocellum have been inserted into transgenic mice to allow the production of endoglucanase. The experiment was intended to learn more about how the digestive capacity of monogastric animals could be improved. Hall et al. published their findings in 1993.
Non-pathogenic strains of Clostridium may help in the treatment of diseases such as cancer. Research shows that Clostridium can selectively target cancer cells. Some strains can enter and replicate within solid tumours. Clostridium could, therefore, be used to deliver therapeutic proteins to tumours. This use of Clostridium has been demonstrated in a variety of preclinical models.[16]
Mixtures of Clostridium species, such as a mixtures of C. beijerinckii, C. butyricum, and species from other genera have been shown to produce biohydrogen from yeast waste.[17]
This genus like several others has undergone a number of revisions with the increasing availability of genomic data. An analysis of a number of proteins from a number of members of this genus has suggested another revision.[18] The main findings of this study were:
It has been proposed to create six new genera accommodate the 78 validly described species that do not appear to be Clostridia. These genera are: Erysipelatoclostridium, Gottschalkia, Lachnoclostridium, Peptoclostridium, Ruminiclostridium and Tyzzerella.
Under this proposal the species Clostridium difficile would become Peptoclostridium difficile.
|
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「細菌の鑑別」「メトロニダゾール」「クロストリジウム属」「芽胞」「clostridial」 |
拡張検索 | 「Clostridium thermocellum」「Clostridium kluyveri」 |
関連記事 | 「clostridium」 |
菌種 | 形態 | 抗酸性 | 芽胞 | 運動性 | 空気中での発育 | 嫌気条件下での発育 | カタラーゼ | オキシダーゼ | ブドウ糖分解 | OF試験 |
Micrococcus | C | - | - | - | + | - | + | - | D | O/- |
Staphylococcus | C | - | - | - | + | + | + | - | + | F |
Aerococcus | C | - | - | - | + | W | W/- | - | + | F |
Streptococcus | C | - | - | +/- | + | + | - | - | + | F |
Pediococcus | C. | - | - | - | + | + | - | - | + | F |
Gemella | ||||||||||
嫌気性球菌*1 | C | - | - | - | - | + | - | - | +/- | F/- |
Kurthia | R | - | - | + | + | + | + | - | - | - |
Corynebacterium | R | - | - | - | + | + | + | - | +/- | F/- |
Listeria | R | - | - | + | + | + | + | - | + | F |
Erysipelothnx | R | - | - | + | + | + | F | |||
Lactobacillus | ||||||||||
Arachnia*2 | ||||||||||
Rothia | R | - | - | - | + | - | + | ● | + | F |
Propiombacterium | R | - | - | - | - | + | + | . | + | F |
Achnomyces | R | - | - | - | - | + | - | ● | + | F |
Bifidobacterium | ||||||||||
Eubacterium | R | - | - | - | - | + | - | . | +/- | F/- |
Clostridium | R | - | <+> | D | - | + | - | ● | D | F/- |
Bacillus | R | - | <+> | D | + | D | + | d | D | F/O/- |
Nocardia | R | W | - | - | + | - | + | - | + | O |
Mycobacterium | R | + | - | - | + | . | + | - | + | O/NT |
*1:Peptococcus, Peptostreptococus(あるいは Leuconostoc) *2:あるいはActinomyces odontolyticus D:その属の菌種によって反応が異なる。 d: 菌種によって反応が異なる。 F:発酵 O:酸化 W:弱反応 ・:不明 NT:テストできない <+>:芽胞非形成筋もある C:球菌 R:桿菌 |
菌種 | 形態 | 運動性 | 空気中での発育 | 嫌気条件下での発育 | カタラーゼ | オキシダーゼ | ブドウ糖(酸) | OF試験 |
Bacteroides | R | - | - | + | d | - | D | F/- |
Veillonella | C | - | - | + | D | ・ | - | - |
Neissena | C | - | + | - | + | + | + | O |
Branhamella | C | - | + | - | + | + | - | - |
Acinetobacter | C/R | - | + | - | + | - | + | O |
Moraxella | R | - | + | + | + | - | ||
Brucella | ||||||||
Bordetella | ||||||||
Chromobacterium lividum | R | + | + | - | + | + | + | O |
Alcahsenes | R | + | + | - | + | + | - | - |
Flavobacterium | R | - | + | - | + | + | + | O |
Pseudomonas | R | + | + | + | + | + | + | O |
Actinobacillus | R | - | + | + | + | + | + | F |
Pasteurella | ||||||||
Necromonas | ||||||||
Cardiobacterium | R | - | + | + | - | + | + | F |
Chromobacterium violaceum | ||||||||
Beneckea | R | + | + | + | + | + | + | F |
Vibrio | ||||||||
Plesiomonas | ||||||||
Aeromonas | ||||||||
腸内細菌 | R | D | + | + | + | - | + | F |
Haemophilus | R | - | + | + | D | - | D | NT |
Eikenella | R | - | -* | + | - | + | - | - |
Campylobacter | R | + | -+1 | - | D | + | - | - |
Streptobacillus+2 | R | - | + | + | - | - | + | F |
マイコプラズマ | ||||||||
*1:Peptococcus, Peptostreptococus(あるいは Leuconostoc) *2:あるいはActinomyces odontolyticus D:その属の菌種によって反応が異なる。 d: 菌種によって反応が異なる。 F:発酵 O:酸化 W:弱反応 ・:不明 NT:テストできない <+>:芽胞非形成筋もある C:球菌 R:桿菌 ・: 不明 *: 空気中では発育せず。空気CO2で発育。+1: 好気的または嫌気的には発育せず。5-6%O2中で発育。+2: あるいはShigella dysenteriae 1 |
.